Spatial Multiomic Services on G4X

Access G4X in situ sequencing technology for cost-effective spatial multiomic services.

Get in contact
Transcript, protein, and fH&E readout of tonsil cancer FFPE serial sections (10x10 mm). Data generated on a single flow cell.

Single Cell Multiomic Analysis

Your project will be run on the G4X Spatial Sequencer, delivering high-resolution targeted transcriptomic, proteomic, and fluorescent H&E (fH&E) insights from each FFPE sections.

EXPLORE G4X

Choose a Tissue-Specific Panel or Customize Your Content

Unlock multiomic insights with our immuno-oncology (IO) transcriptomic and proteomic panels across selected human FFPE tissues, or choose the customization option that suits your specific project needs.

VIEW AVAILABLE PANELS
300-Plex G4X Transcriptomic Panel on FFPE Kidney Tissue

Services Overview

We’re here to help guide you through your experiments every step of the way to ensure project success.  Every project will receive white glove service from project planning through data review.

Project Consultation

Sample Acquisition

G4X Spatial Sequencing

Data Review & Delivery

Get Started With Your Project Today

Unlock insights with our immuno-oncology (IO) transcriptomic and multiomic panels across select supported human FFPE tissues.

Type Tier Panel Content Sample Types

Transcriptomics

(+fH&E) 		Standard
300 Genes
  • 150 Immune Oncology
  • 50 Stromal Architecture
  • 100 Tissue Markers
  • Tonsil
  • Lymph
  • Breast
  • Lung
  • Kidney
  • Colon
  • Other (Inquire*)
Plus
325 Genes
  • Standard Content
  • +25 Gene Custom Add-on
Advanced 300 Custom Genes

Multiomics

(Transcripts, Proteins, fH&E) 		Standard
12 Proteins, 300 Genes
  • 12 Immune Proteins
  • 150 Immune Oncology
  • 50 Stromal Architecture
  • 100 Tissue Markers
Plus
12 Proteins, 325 Genes
  • Standard Content
  • +25 Gene Custom Add-on
Advanced 12+ Proteins, 300 Custom Genes

*New tissue testing fee may apply
Control sample in each flow cell is included

Connect with a Spatial Expert

Discuss your project goals with a member of the Singular team to get started.

Get in contact
Product in Development.  SPECIFICATIONS SUBJECT TO CHANGE. For Research Use Only.

Technology Access Services Information

Please provide your information and a member of the team will be in contact to provide more information on the Technology Access Services.

Download the Gene List

Please provide your information to download the gene list.

Drew Spaventa

Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018.

Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.

Drew Spaventa

Max Reads Application Note